PTC Therapeutics Inc. | Key People and Executives
Stuart W. Peltz
Chief Executive Officer & Director
Michael Schmertzler
Chairman
Dawn Svoronos
Independent Director
Glenn D. Steele
Independent Director
Jerome B. Zeldis
Independent Director
David P. Southwell
Independent Director
Allan Steven Jacobson
Independent Director
Stuart W. Peltz
Chief Executive Officer & Director
Marcio Souza
Chief Operating Officer
Christine Utter
Principal Financial Officer & Treasurer
Neil Gregory Almstead
Executive VP-Research, Operations & Technology
Ellen Welch
SVP-Genetic Disorders & Translational Medicine
Edward O'Mara
Vice President Clinical Development-Oncology
Christopher Trotta
Vice President-R&D Biology
Anu Bhattacharyya
Director
Joseph McIntosh
SVP & Head-Clinical Development
Eric Pauwels
Senior Vice President & GM-Commercial Operations
Adrian J. Haigh
Senior Vice President & GM-EMEA Region
Murad Husain
Vice President-Regulatory Affairs
Emily Hill
Head-Investor Relations
Jane Baj
Head-Media Relations
Martin Rexroad
Senior Vice President-Human Resources
Megan Sniecinski
Secretary & Senior Vice President
Mark Elliott Boulding
Chief Legal Officer & Executive Vice President
Michael Schmertzler
Chairman
Dawn Svoronos
Independent Director
Glenn D. Steele
Independent Director
Jerome B. Zeldis
Independent Director
David P. Southwell
Independent Director
Allan Steven Jacobson
Independent Director
| Address |
100 Corporate Court
South Plainfield New Jersey 07080
United States
|
|
Employees
|
- |
| Website |
http://www.ptcbio.com |
| Updated |
07/08/2019 |
| PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel medicines using its expertise in RNA biology. The company's internally discovered pipeline addresses multiple therapeutic areas, including rare disorders and oncology. It is focused on developing treatments to fundamentally change the lives of patients living with rare genetic disorders. |
